Welcome to our dedicated page for Inverse VIX Short-Term Futures ETNs due March 22, 2045 SEC filings (Ticker: VYLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Inverse VIX Short-Term Futures ETNs due March 22, 2045 (VYLD) brings together U.S. regulatory documents in which this security is formally identified. In multiple Form 8-K current reports filed by JPMorgan Chase & Co., VYLD appears in the table of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934.
In those filings, the Title of each class is given as the Guarantee of Inverse VIX Short-Term Futures ETNs due March 22, 2045 of JPMorgan Chase Financial Company LLC, the Trading Symbol is listed as VYLD, and the Name of each exchange on which registered is NYSE Arca, Inc. The same tables also list JPMorgan Chase & Co. common stock, depositary shares representing interests in various preferred stock series, and other guaranteed notes and ETNs.
Through this page, users can access the underlying Form 8-K reports and related exhibits where VYLD is mentioned. These filings may cover topics such as earnings releases, changes to by-laws, or the closing of public offerings of other notes and subordinated debt, with VYLD included in the standardized disclosure of registered securities.
Stock Titan enhances these filings with AI-powered summaries that explain the main points of each document in plain language, while still preserving access to the full official text from EDGAR. Users can quickly see where VYLD appears in the filing, understand the context of the report, and navigate to other securities listed in the same disclosure table.
For deeper analysis, investors can review successive filings over time to confirm that VYLD remains listed as a registered security and to see how it is grouped with other instruments issued or guaranteed by JPMorgan Chase & Co. and JPMorgan Chase Financial Company LLC.
J.P. Morgan has filed a Rule 424(b)(3) index supplement for structured notes linked to the MerQube US Gold Vol Advantage Index (“the Index”). The document provides investors with back-tested monthly and annual returns from December 2007 to February 2025 and actual performance from 11 Feb 2025 to 30 Jun 2025. Reported calendar-year backtests show double-digit gains in several periods (e.g., 76.74 % in 2009, 60.75 % in 2018, 63.85 % in 2023) but also deep draw-downs (-61.69 % in 2012, -40.54 % in 2014), illustrating the strategy’s high volatility.
The Index is a rules-based, gold futures strategy that seeks to target a defined volatility by adjusting both leverage and cash exposure; however, its level is reduced by a 6 % per-annum daily deduction and represents excess return only (no interest on collateral). It began live calculation on 11 Feb 2025, so most performance data are hypothetical and subject to the limitations of back-testing.
Key risk disclosures highlighted in the filing:
- Index established in 2025; limited live history and potential model risk.
- May not achieve the stated volatility target and can employ significant leverage.
- Potentially large uninvested cash allocations and negative roll yield from futures term structure.
- Concentration in gold futures exposes investors to commodity-specific shocks.
- Daily 6 % fee and excess-return methodology create structural performance drag.
- JPMS helped design the Index and licenses it from MerQube, creating conflicts of interest.
Neither the SEC nor state regulators have approved the notes. They are not FDIC-insured and carry issuer credit risk. Past or back-tested returns are explicitly not indicative of future results. Investors are urged to review the full Risk Factors in the prospectus supplement, product supplement, underlying supplement and any final pricing supplement.